|
Scleritis
|
D015423 |
[Refers to any inflammation of the sclera including episcleritis, a benign condition affecting only the episclera, which is generally short-lived and easily treated. Classic scleritis, on the other hand, affects deeper tissue and is characterized by higher rates of visual acuity loss and even mortality, particularly in necrotizing form. Its characteristic symptom is severe and general head pain. Scleritis has also been associated with systemic collagen disease. Etiology is unknown but is thought to involve a local immune response. Treatment is difficult and includes administration of anti-inflammatory and immunosuppressive agents such as corticosteroids. Inflammation of the sclera may also be secondary to inflammation of adjacent tissues, such as the conjunctiva.
] |
|
Laryngeal Edema
|
C09.400.313 |
|
|
Platelet-Derived Growth Factor
|
D12.776.467.910 |
|
|
Mouth Protectors
|
E06.761.599 |
|
|
Thoracic Duct
|
A15.382.520.301.750 |
|
|
Ceramides
|
D02.065.313 |
|
|
Appendiceal Neoplasms
|
C04.588.274.476.411.184.290 |
|
|
Arthritis, Psoriatic
|
C17.800.859.675.175 |
|
|
Psoriasis
|
C17.800.859.675 |
|
|
Anabaena cylindrica
|
B03.440.475.100.100.150 |
|
|
Borates
|
D01.248.497.158.076 |
|
|
Cell Migration Assays
|
E01.370.225.812.125 |
|
|
Leprosy, Borderline
|
D015439 |
[A form of LEPROSY in which there are clinical manifestations of both principal types (lepromatous and tuberculoid). The disease may shift toward one of these two polar or principal forms.
] |
|
Tetracycline Resistance
|
G06.225.347.937 |
|
|
Health Behavior
|
D015438 |
[Combination of HEALTH KNOWLEDGE, ATTITUDES, PRACTICE which underlie actions taken by individuals regarding their health.
] |
|
Cimetidine
|
D03.383.129.308.130 |
|
|
Musculoskeletal and Neural Physiological Phenomena
|
G11 |
|
|
Virgibacillus
|
B03.300.390.400.158.900 |
|
|
Virtues
|
F01.829.500.840 |
|
|
Angina, Unstable
|
C14.907.585.187.150 |
|
